Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
ergolines
Description:
A family of alkaloid compounds containing the ergoline chemical structure, including substances studied for neurological and pharmacological effects.
Related topics:
Receptor Mechanisms and Signaling (13%),
Psychedelics and Drug Studies (11%),
Neurotransmitter Receptor Influence on Behavior (11%),
Alkaloids: synthesis and pharmacology (10%)
Wikidata ID:
wiki/Q49873234
OpenAlex ID:
keywords/ergolines
Molecular pharmacology of 5-HT1D recognition sites: Radioligand binding studies in human, pig and calf brain membranes
1988
·
C. Waeber
, P. Schoeffter
, et al.
·
Naunyn-Schmiedeberg s Archives of Pharmacology
·
180
Biotechnology and genetics of ergot alkaloids
2001
·
P. Tudzynski
, T. Correia
, et al.
·
Applied Microbiology and Biotechnology
·
169
Resolution and absolute configuration of an ergoline-related dopamine agonist, trans-4,4a,5,6,7,8,8a,9-octahydro-5-propyl-1H(or 2H)-pyrazolo[3,4-g]quinoline
1983
·
Robert D. Titus
, Edmund C. Kornfeld
, et al.
·
Journal of Medicinal Chemistry
·
126
Chemistry and Structure–Activity Relationships of Psychedelics
2017
·
David E. Nichols
·
Current topics in behavioral neurosciences
·
123
Pharmacologic characterization of the human 5-hydroxytryptamine2B receptor: evidence for species differences.
1996
·
D B Wainscott
, V L Lucaites
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
121
Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines.
1994
·
M P Johnson
, R J Loncharich
, et al.
·
Molecular Pharmacology
·
117
Lisuride, a Dopamine Receptor Agonist With 5-HT2B Receptor Antagonist Properties: Absence of Cardiac Valvulopathy Adverse Drug Reaction Reports Supports the Concept of a Crucial Role for 5-HT2B Receptor Agonism in Cardiac Valvular Fibrosis
2006
·
C. Hofmann
, U. Penner
, et al.
·
Clinical Neuropharmacology
·
115
Structure–activity relationships of serotonin 5‐HT2Aagonists
2012
·
David E. Nichols
·
Wiley Interdisciplinary Reviews Membrane Transport and Signalling
·
96
PDF
Derivatives as 5HT1A Receptor Ligands-Past and Present
2005
·
G. Caliendo
, V. Santagada
, et al.
·
Current Medicinal Chemistry
·
92
5-HT2A receptors: Pharmacology and functional selectivity
2025
·
Benjamin R. Cummins
, Gerald B. Billac
, et al.
·
Pharmacological Reviews
·
86
Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
1996
·
N Almaula
, B J Ebersole
, et al.
·
Molecular Pharmacology
·
84
Identification of a 5-HT1 recognition site in human brain membranes different from 5-HT1A, 5-HT1B and 5-HT1C sites
1988
·
D. Hoyer
, C. Waeber
, et al.
·
Neuroscience Letters
·
79
Resolved monophenolic 2-aminotetralins and 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines: structural and stereochemical considerations for centrally acting pre- and postsynaptic dopamine-receptor agonists
1985
·
Haakan Wikstroem
, Bengt Andersson
, et al.
·
Journal of Medicinal Chemistry
·
76
Dynamic calibration of mechanically, air- and electromagnetically braked cycle ergometers
1998
·
B. F. Maxwell
, R. T. Withers
, et al.
·
European Journal of Applied Physiology
·
66
A homology-based model of the human 5-HT2A receptor derived from an in silico activated G-protein coupled receptor
2002
·
James J. Chambers
, David E. Nichols
·
Journal of Computer-Aided Molecular Design
·
55
Structure–Activity Relationship Analysis of Psychedelics in a Rat Model of Asthma Reveals the Anti-Inflammatory Pharmacophore
2020
·
Thomas W. Flanagan
, Gerald B. Billac
, et al.
·
ACS Pharmacology & Translational Science
·
53
Octahydrobenzo[g]quinolines: potent dopamine agonists which show the relationship between ergolines and apomorphine
1985
·
Rene Nordmann
, Trevor J. Petcher
·
Journal of Medicinal Chemistry
·
52
Differential Effects of Three Dopamine Agonists: Apomorphine, Bromocriptine and Lergotrile
1977
·
Ellen K. Silbergeld
, R. F. Pfeiffer
·
Journal of Neurochemistry
·
51
Species differences in the pharmacology of the 5-hydroxytryptamine2 receptor: structurally specific differentiation by ergolines and tryptamines.
1993
·
D L Nelson
, V L Lucaites
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
48
Central dopamine agonistic activity and microsomal biotransformation of lisuride, lergotrile and bromocriptine
1979
·
H.H. Keller
, M. Da Prada
·
Life Sciences
·
47
Reconstituting the complete biosynthesis of D-lysergic acid in yeast
2022
·
Garrett Wong
, Li Rong Lim
, et al.
·
Nature Communications
·
44
PDF
Physiologic disposition of pergolide
1981
·
Alan Rubin
, Louis Lemberger
, et al.
·
Clinical Pharmacology & Therapeutics
·
43
Stimulant and hallucinogenic novel psychoactive substances; an update
2023
·
F Schifano
, A Vento
, et al.
·
Expert Review of Clinical Pharmacology
·
42
PDF
Ergot alkaloids. Ergolines and related compounds as inhibitors of prolactin release
1974
·
John M. Cassady
, George S. Li
, et al.
·
Journal of Medicinal Chemistry
·
42
Interaction of Tryptamine and Ergoline Compounds with Threonine 196 in the Ligand Binding Site of the 5-Hydroxytryptamine6 Receptor
1997
·
Frank G. Boess
, Frederick J. Monsma
, et al.
·
Molecular Pharmacology
·
40
Show more works
View as search
Works count:
160
Citation count:
3,080
Year
Topic
Type